These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32302607)

  • 21. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
    Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
    Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review.
    Ya K; Tangamornsuksan W; Scholfield CN; Methaneethorn J; Lohitnavy M
    Asian J Psychiatr; 2019 Jun; 43():73-82. PubMed ID: 31100603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Toxicity Assessment of Kratom Decoction, Mitragynine and Speciociliatine Versus Morphine on Zebrafish (
    Damodaran T; Chear NJ; Murugaiyah V; Mordi MN; Ramanathan S
    Front Pharmacol; 2021; 12():714918. PubMed ID: 34489704
    [No Abstract]   [Full Text] [Related]  

  • 24. Development, validation, and application of an LC-MS/MS method for mitragynine and 7-hydroxymitragynine analysis in hair.
    Meier U; Mercer-Chalmers-Bender K; Scheurer E; Dussy F
    Drug Test Anal; 2020 Feb; 12(2):280-284. PubMed ID: 31833662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice.
    Ismail NIW; Jayabalan N; Mansor SM; Müller CP; Muzaimi M
    Addict Biol; 2017 Jul; 22(4):967-976. PubMed ID: 26990882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abuse potential and adverse cognitive effects of mitragynine (kratom).
    Yusoff NH; Suhaimi FW; Vadivelu RK; Hassan Z; Rümler A; Rotter A; Amato D; Dringenberg HC; Mansor SM; Navaratnam V; Müller CP
    Addict Biol; 2016 Jan; 21(1):98-110. PubMed ID: 25262913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
    Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
    Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry.
    Philipp AA; Wissenbach DK; Zoerntlein SW; Klein ON; Kanogsunthornrat J; Maurer HH
    J Mass Spectrom; 2009 Aug; 44(8):1249-61. PubMed ID: 19536806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes.
    Lu J; Wei H; Wu J; Jamil MF; Tan ML; Adenan MI; Wong P; Shim W
    PLoS One; 2014; 9(12):e115648. PubMed ID: 25535742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A drug toxicity death involving propylhexedrine and mitragynine.
    Holler JM; Vorce SP; McDonough-Bender PC; Magluilo J; Solomon CJ; Levine B
    J Anal Toxicol; 2011 Jan; 35(1):54-9. PubMed ID: 21219704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitragynine concentrations in two fatalities.
    Domingo O; Roider G; Stöver A; Graw M; Musshoff F; Sachs H; Bicker W
    Forensic Sci Int; 2017 Feb; 271():e1-e7. PubMed ID: 28089300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
    Fowble KL; Musah RA
    Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of mitragynine in urine matrices by bar adsorptive microextraction and HPLC analysis.
    Neng NR; Ahmad SM; Gaspar H; Nogueira JM
    Talanta; 2015 Nov; 144():105-9. PubMed ID: 26452798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.
    Hughes RL
    Forensic Sci Med Pathol; 2019 Mar; 15(1):110-113. PubMed ID: 30498933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton.
    Kronstrand R; Roman M; Thelander G; Eriksson A
    J Anal Toxicol; 2011 May; 35(4):242-7. PubMed ID: 21513619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real time monitoring of dopamine release evoked by mitragynine (Kratom): An insight through electrochemical sensor.
    Effendy MA; Yunusa S; Zain ZM; Hassan Z
    Neurosci Lett; 2021 Oct; 763():136183. PubMed ID: 34418508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico investigation of mitragynine and 7-hydroxymitragynine metabolism.
    Limpanuparb T; Noorat R; Tantirungrotechai Y
    BMC Res Notes; 2019 Jul; 12(1):451. PubMed ID: 31331383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abuse liability of mitragynine assessed with a self-administration procedure in rats.
    Yue K; Kopajtic TA; Katz JL
    Psychopharmacology (Berl); 2018 Oct; 235(10):2823-2829. PubMed ID: 30039246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine.
    Papsun DM; Chan-Hosokawa A; Friederich L; Brower J; Graf K; Logan B
    J Anal Toxicol; 2019 Sep; 43(8):615-629. PubMed ID: 31424079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.